NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to ...
Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.
In a history-making exercise, the Fudan University in Shanghai (China) not only broke a previously held record but managed to ...
IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.
High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...
A lot has happened globally since Trump’s first term. Among US allies & adversaries, a guessing game has begun ...
Scientists have successfully immortalized lip cells, creating a clinically relevant lab model that enables testing of new ...
The meeting brought together doctors and scientists to explore cutting-edge healthcare technologies. Organised by the AAHII ...
The Cool Down on MSN2h
Scientists make game-changing breakthrough with next-generation power source — here's how it works"If [the] technology is successfully developed, it will enable efficient energy management," KIST researcher Ho-Il Ji said in ...
A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.
Detailed price information for Creative Medical Technology Holdings Inc (CELZ-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback